Acetyl-L-carnitine prevents and reduces paclitaxel-induced painful peripheral neuropathy [PMID: 16406309] Laboratory literature summary: Acetyl-L-carnitine prevents and reduces paclitaxel-induced painful peripheral neuropathy
Endocrinology 151:14731486 Hegedus L, Moses AC, Zdravkovic M, Le Thi T, Daniels GH (2001) GLP-1 and calcitonin concentration in humans: lack of evidence of calcitonin release from sequential screening in over 5000 subjects with type 2 diabetes or nondiabetic obese subjects treated with the human GLP-1 analog, liraglutide
This bundle is ideal for researchers working in a scientific or laboratory environment
doi: 10.3389/fmed.2022.875430 Summary Keywords glucagon-like peptide-1 receptor agonist (GLP-1RA), incretin based therapy, glucose-depent insulinotropic peptide (GIP), dual agonists, tirzepatide, type 2 diabetes Citation Gallwitz B (2022) Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity
Research recommends 1.2 to 1.6g of protein per kilogram of body weight daily to preserve muscle mass during weight loss 1